Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial
Titel:
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial
Auteur:
Wassil, James Sisti, Maggie Fairman, Jeff Davis, Matthew Fierro, Carlos Bennett, Sean Johnson, Derek Migone, Thi-Sau Nguyen, Kien Sauer, Paul Currie, Michelle Iki, Sam Simon, Jakub K